Headline Sponsor

The University of Glasgow’s College of Medical, Veterinary and Life Sciences brings together internationally renowned experts and state-of-the-art facilities to improve health and quality of life for humans and animals across the globe.

The College has a track record of leading on research innovation and successful collaborations with partners to achieve shared ambitions, such as the world-leading academic developments at the Queen Elizabeth University Hospital (QEUH), establishing Glasgow as a world-leader in precision medicine. A key enabler of this success has been the multidisciplinary approach bringing together Academia, Industry and the NHS within the Clinical Innovation Zone at the QEUH.

The College is organised into seven Research Institutes and three Schools. Our Institutes focus on key cross-disciplinary research themes, such as One Health, Addressing Inequalities, and Precision Medicine & Chronic Disease. Our expertise in the latter is such that we have been chosen by the UK Government to lead a Science and Innovation Audit on Precision Medicine Innovation in Scotland.

Supporting Sponsors

Concept Life Sciences provides integrated, high quality drug discovery, development and analytical services to the life science sector. Formed as a result of targeted acquisition and organic growth, the Company has the in-house expertise and resource to support customers with projects spanning from target discovery to the clinic, adding value and IP throughout the discovery pathway.

With a track record of delivering knowledge-based, science-led solutions, the Company employs over 700 FTEs, including more than 500 highly skilled, experienced scientists, supporting its global client base from 10 state of the art laboratory facilities.

Concept Life Sciences has worked with all of the top 10 pharma and biotech companies, and is targeting revenues exceeding $60m in 2017. Having experienced rapid growth, the Company remains focused on problem solving, quality, collaboration, and flexibility.

We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.

We have 3 global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products.

Our goal is to be one of the world’s most innovative, best performing and trusted healthcare companies.

We aim to bring differentiated, high-quality and needed products to as many people as possible, with our 3 global businesses, scientific and technical knowhow and talented people.

Highlands and Islands Enterprise (HIE) is the economic and community development agency delivering the Scottish Government’s economic strategy across the north and west of Scotland, a region which covers more than half of Scotland.

With around 300 staff, HIE supports hundreds of client businesses and social enterprises; strengthens communities, particularly in fragile areas; develops key sectors, and invests in infrastructure to create a more competitive and low carbon region.

As one of our priority sectors for growth, Life Sciences are key to the economic development of our region. In particular the sub-sectors Medical Technologies and Diagnostics, Digital Health and Marine Biotechnology play an important role and are well represented across the business base and academic expertise.

BioReliance Services, a life science leader, is a business of Merck KGaA, Darmstadt, Germany. Our products and services help you safely and efficiently develop and manufacture therapeutics.

With locations worldwide and experience with a variety of therapeutic drug products, BioReliance offers more than 1,000 tests and complementary services related to biologics safety testing. Our comprehensive service offering includes:

  • Biosafety Testing of biologicals for viruses, bacteria, mycoplasma, fungi
  • Cell Line Characterization including identity, genetic stability, sequencing
  • Final Product Testing including residual DNA, host cell proteins
  • Virus / TSE Validation Studies– viral clearance studies
  • Contract GMP Production and Testing – viral vectors, cell banks

Home to GlaxoSmithKline, RUA Medical, GS Biotech, Barony Universal Products and others, North Ayrshire offers a successful and well connected place to do business.  Our premier business location, i3 – Scotland’s Life Science Enterprise Area – is continuing to expand and the Council is investing £10m in further development of sites and workspace.

Located on the West coast of Scotland, just south of Glasgow City, North Ayrshire Council plays a leading role in improving the lives of North Ayrshire’s people and is committed to building a vibrant local economy which contributes to the UK and Scotland’s economic success. Generating 7.9% of Scottish turnover and contributing 10.3% to Scotland’s GVA from life sciences manufacturing, the area is an important player in this critical sector.

Event App Sponsor

Symbiosis Pharmaceutical Services is a contract manufacturing organisation (CMO) that specialises in the GMP manufacture and sterile fill/finish of vials for clinical trials and low-volume commercial supply. Regulatory compliance, technical capability and operational flexibility are at its core.

Manufacturing takes place in a purpose-built MHRA-licensed facility, enabling the CMO to handle products that require aseptic liquid filling and lyophilisation for a range of complex biologics, viral vectors for use in gene therapies and small molecule drugs.

Offering fast access to manufacturing slots and accelerated release of drug product, Symbiosis is primed to meet demand for small-scale, fast-turnaround drug product manufacturing, while maintaining regulatory compliance to the highest standards.

Award Category Sponsors

Booth Welsh is an integrated engineering services business delivering multi-discipline process control and automation solutions globally. The company delivers a full lifecycle service providing the client with an efficient and innovative end to end approach to projects.

Booth Welsh has a solid track record in the life & chemical sciences sector specialising in driving process improvements to optimise efficiency, reduce costs, and increase yields.  More recently our state-of-the-art technology and unrivalled engineering expert teams have enhanced engagement with key clients and technology suppliers to embrace digitalisation.

Our reputation has been built up over 28 years’ delivering business solutions to clients across the world working collaboratively with our partners including companies such as GlaxoSmithKline, Merck, and Novartis.

Concept Life Sciences provides integrated, high quality drug discovery, development and analytical services to the life science sector. Formed as a result of targeted acquisition and organic growth, the Company has the in-house expertise and resource to support customers with projects spanning from target discovery to the clinic, adding value and IP throughout the discovery pathway.

With a track record of delivering knowledge-based, science-led solutions, the Company employs over 700 FTEs, including more than 500 highly skilled, experienced scientists, supporting its global client base from 10 state of the art laboratory facilities.

Concept Life Sciences has worked with all of the top 10 pharma and biotech companies, and is targeting revenues exceeding $60m in 2017. Having experienced rapid growth, the Company remains focused on problem solving, quality, collaboration, and flexibility.

Haseltine Lake is a major European Intellectual Property practice. With decades of experience in helping life sciences businesses protect their valuable innovations, Haseltine Lake can unlock the power of your IP.

Our team of highly qualified attorneys across a number of European offices in Glasgow, London, Bristol, Munich and the Netherlands, can help you get the protection you need, and make your IP budget go further.  Founded in 1850, Haseltine Lake enjoys long-standing, closely integrated relationships with its clients, based on trust, transparency and flexibility.

Opportunity North East (ONE) is the private sector’s response to the long-term economic challenges facing North East Scotland.

Industry-led and privately funded, ONE works in partnership and co-invests with the private and public sector to deliver transformational projects.

ONE’s Life Sciences vision is to build on the successful and growing life sciences cluster in Aberdeen by accelerating the creation, development, growth and attraction of high growth businesses and investing in infrastructure, through the development of a Life Sciences Hub to capitalise on our regional assets at Europe’s largest integrated medical research and teaching location, the Forresterhill campus.

Outstanding Contribution Award Sponsor

Waters creates business advantages for laboratory-dependent organizations by delivering practical and sustainable scientific innovation to enable significant advancement in healthcare delivery, environmental management, food safety, and water quality.

Waters Division products are used by pharmaceutical, life science, biochemical, industrial, academic and government organizations working in research and development, quality assurance and other laboratory applications.

Waters UPLC, HPLC and MS instruments and consumables are used in a broad range of industries to measure the chemical, physical and biological composition of materials.

Media Partner

The Scotsman is proud to support the Life Sciences Industry in Scotland by raising awareness, fostering discussion, identifying challenges and celebrating success for the benefit of our readers and society at large.

Scotsman Editorial Director Frank O’Donnell believes that Scotland’s National Newspaper has a vital role to play in profiling key sectors such as Life Sciences.

“Through our daily printed editions, our significant online reach via scotsman.com, industry focused content series and the annual Scotsman Life Sciences Conference we are delighted to be part of developing and delivering the industry’s bold vision” says Frank.

For more information please contact:

Adam Fenech, Business Development Manager

The Scotsman Publications Ltd

adam.fenech@jpress.co.uk / 07885 982 183